Evidence map›Paper›PMID 30483100›Full record

ArticleCase reports in oncology

The Smallest Reported Malignant Struma Ovarii: A Case Report.

Nobuko Yasutake, Hirotsugu Noguchi, Yuta Ibayashi, Hiroaki Nakamura, Kazuki Tateishi, Kotaro Yuki, Ryuji Shiina, Shohei Shimajiri, Takuji Fujita

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nobuko YasutakeDepartment of Gynecology and Obstetrics, Tagawa Municipal Hospital, Fukuoka, Japan.
Hirotsugu NoguchiDepartment of Pathology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Yuta IbayashiDepartment of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
Hiroaki NakamuraDepartment of Clinical Laboratory, Tagawa Municipal Hospital, Fukuoka, Japan.
Kazuki TateishiDepartment of Clinical Laboratory, Tagawa Municipal Hospital, Fukuoka, Japan.
Kotaro YukiDepartment of Gynecology and Obstetrics, Tagawa Municipal Hospital, Fukuoka, Japan.
Ryuji ShiinaDepartment of Gynecology and Obstetrics, Tagawa Municipal Hospital, Fukuoka, Japan.
Shohei ShimajiriDepartment of Pathology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Takuji FujitaDepartment of Gynecology and Obstetrics, Tagawa Municipal Hospital, Fukuoka, Japan.
Naga Municipal Hospital · JPUniversity of Occupational and Environmental Health Japan · JPKyushu University Beppu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMalignant struma ovarii is a rare neoplasm. It is usually asymptomatic and not commonly diagnosed preoperatively. In addition, there is currently no established diagnostic and therapeutic approach for malignant struma ovarii. CASE REPORT: A 66-year-old asymptomatic female was referred to our hospital. Computed tomography showed the presence of a well-defined mass with enhancement in the internal and peripheral areas. The patient underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and partial omentectomy. Histopathology revealed the presence of a papillary thyroid carcinoma arising from a 2.5-cm-diameter struma ovarii (malignant struma ovarii). According to the criteria of the International Federation of Gynecology and Obstetrics, the patient had stage IA disease. Subsequently, she underwent a thyroid scan with normal findings. At the 3-month follow-up, the patient was alive, in good clinical condition, and disease free.

conclusionIn this report, we present the smallest malignant struma ovarii reported so far in the literature. Because of the rarity of these tumors and the lack of firm prognostic factors, the treatment decision should be customized for each patient according to the pathological and clinical parameters.

Indexed as

BRAFMalignant papillary thyroid carcinomaStruma ovarii

Identifiers

PMID30483100
PMCPMC6244102
OpenAlexW2899386951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.